Examining early use of GLP-1 RAs in T2DM

Location:

Courtyard Marriott, 1224 Upper James St. Hamilton, On. L9C 3B1

Presenter:

Dr. Vladimir Milosevic

Metformin therapy alone wasn’t enough to achieve glycemic control—what’s next? Uncover the evolving discussion on this topic through our interactive session. Together, we will discover the reasons behind why GLP-1 RAs may be considered an appropriate second-line option in this setting, as recommended by the Diabetes Canada guidelines. Driven by patient vignettes, we will examine the latest evidence behind the decisions guiding our patient’s journey—and why GLP-1 RAs may make for a good fit.

Program objectives

1. Explain the pathophysiology of obesity as a chronic disease, and discuss the rationale for and potential impact of obesity management
2. Identify available obesity treatment options and explore strategies for integrating them into a patient-management plan
3. Discuss practical approaches to overcoming challenges in the management of obesity

Download invitation

Learning Objectives:

• Review guideline recommendations and discuss best practice strategies for adult vaccination.
• Identify medications that increase the risk of infections or impact the efficacy of immunization.
• Recognize how immune mediated inflammatory diseases increase the risk of infections.
• Understand opportunities for community pharmacists in recommending vaccines.

Speaker:

• Carolyn Whiskin, RPh, BScPhm, NCMP, Charlton Health Inc

Date/Location/Time:

• Wednesday September 25th 2019
• Royal Botanical Gardens, 680 Plains Road West, Burlington, ON
• Arrivals 6:30pm, Presentation starts 7:00pm

Download invitation

Faculty:

• Anatoli Chkaroubo, BScPhm, RPh, ACPR
• Kirk Wong, BScPhm

Learning Objectives:

• Review biosimilar R&D pathway and HC regulatory requirements
• Become familiarized with new HC biosimilar nomenclature and prescribing / dispensing requirements
• Discuss role of G-CSF in oncology and the management of febrile neutropenia and stem cell mobilization
• Introduce the latest G-CSF biosimilars in the Canadian market
• Share clinical pearls and case-based examples

When:

• Tue. July 9th, 2019 Reception at 6:30pm

Where:

• Spencer's at the Waterfront, 1340 Lakeshore Rd, Burlington

Learning Objectives:

1. Identify challenges and benefits to integrating technology into Diabetes Management
2. Reflect on the options available to patients and issues that may affect their choices
3. Recognize ways to discuss monitoring and realistic goals with clients
4. Identify patterns with results
5. Utilize a case study to help build a management plan for your diabetes patients including monitoring, nutrition & activity with connected devices

Speaker:

• Bo Fusek, RN, CDE

Location:

• Liuna Station, 360 James St North, Hamilton

Download invitation

Learning Outcomes:

• Psoriasis treatment options update
• HS Clinical presentation and diagnosis
• Understanding the patient journey
• Review of HS medical management options
• Compare the mechanism of action of IL23p19 inhibitors and other currently available treatments for psoriasis
• Explain the key efficacy and Safety for the new IL23p19

Moderator:

• Carolyn Whiskin, RPh, BScPhm, NCMP, Pharmacist

Speakers:

• Dr. Ron Vender, MD, FRCP, Dermatologist
• Dr. Hermenio Lima, MD, FRCP, PhD, Dermatologist

Venue: Lo Presti's at Maxwell's, 165 Jackson Street East, Hamilton

Download invitation

Outline:

• Review common myths and misconceptions about MTX use.
• Review the "Nocebo" perceptions about MTX common in the community
• Understanding why prescribing subcutaneous Methotrexate vs. Oral methotrexate provides optimal patient care for early treatment of rheumatoid arthritis

Presented by:

• Dr. Sonja Gill, MD, FRCPC, Rheumatology and Internal Medicine, Oakville Trafalgar Memorial Hospital, Credit Valley and Trillium Hospital  

Location:

• The Ancaster Mill, 548 Old Dundas Rd., Ancaster